Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Panitumumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 42 Colonic Neoplasms 14 Rectal Neoplasms 13 Neoplasms 12 Neoplasm Metastasis 12 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Carcinoma, Squamous Cell 4 Breast Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma Of Esophagus 3 Triple Negative Breast Neoplasms 2 Gastrointestinal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Exanthema 1

Interventions

vandetanib 7 Sorafenib 6 Magnetic Resonance Spectroscopy 6 lenvatinib 5 cabozantinib 5 Sunitinib 4 Iodine-131 4 selpercatinib 3 AZD 6244 3 trametinib 2 tipifarnib 2 durvalumab 2 dabrafenib 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Paclitaxel 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Everolimus 2 Bortezomib 2 Axitinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tremelimumab 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡